Shareholder Information
Share management and AGM information
Investors
Results, Reports and Presentations
-
Jefferies Healthcare Conference
June 8 2022 Download (553KB) -
Q1 2022 Financial Results
April 28 2022 Download (627KB) -
Annual Report and Accounts 2021
March 30 2022 Download (4.71MB) -
Q4 and FY 2021 Results
February 16 2022 Download (562KB) -
Jefferies 2021 London Healthcare Conference
November 16 2021 Download (791KB)
Latest News
-
Indivior Names Nina DeLorenzo Chief Global Impact Officer
June 16 2022 -
Indivior Announces Seven Abstracts Accepted for Presentation at the 84th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD)
June 8 2022 -
Indivior Announces First Patient Included in Aelis Farma’s Phase 2b Study Assessing the Efficacy, Safety and Tolerability of AEF0117 in Treatment-Seeking Subjects With Moderate to Severe Cannabis Use Disorder
June 1 2022 -
Indivior Announces Publication of Data Showing Psychosocial Benefits from a 4-year Post-Clinical Trial Outcomes Study
May 26 2022 -
Indivior to Participate in Jefferies 2022 Healthcare Conference
May 26 2022
